Gregory T. Lucier
Chairman of the Board and Chief Executive Officer
Gregory T. Lucier has served as our Chairman and Chief Executive Officer since May 2015. He has served as a member of the NuVasive Board of Directors since December 2013. An established strategic thought leader and business executive in the Life Sciences, Medical Device and Healthcare Technology sectors, Mr. Lucier is a proven game-changer with an eye for innovative technologies that will radically alter healthcare in the 21st century.
Known for his success in the capacity of Chief Executive Officer and in Board Director roles, he has demonstrated expertise in guiding enterprise growth through his focus on the integration of internal operating assets, building innovation capabilities, making accretive acquisitions, creating IP portfolios, expanding globally, and repositioning business models.
As Chairman and CEO of NuVasive, a medical device company that has transformed spine surgery by pioneering minimally invasive lateral approach spine surgery, Mr. Lucier and his team are again pushing the boundaries of medical device innovation with their recently launched, game-changing Integrated Global Alignment™ procedural solution, which is poised to change, yet again, how spine surgery is done.
Mr. Lucier’s vision on the power of genomics to eradicate disease states, such as cancer, led the growth trajectory of Life Technologies Corporation during the eleven years he served as Chairman and CEO.
The company was at the forefront genomics research, providing more than 50,000 laboratory and genomic testing products to customers in 180 countries, holding over 5,000 essential patents, with $4 billion in revenue to the acquisition by Thermo Fisher Scientific in 2013 for $15.6 billion – one of the largest Life Sciences acquisitions to date. Mr. Lucier’s career with General Electric was focused on starting up and transforming major business models. During his tenure he served as President, Medical Information Technologies/GE Healthcare, overseeing the networking of medical electronic devices, digital imaging and clinical information systems with revenues of $1.8 billion. He was promoted by the GE Board to an officer of General Electric Corporation to serve as Vice President Global Services, GE Healthcare, the company’s $2 billion healthcare services business where he successfully led the transformation from a machine maintenance focus to GE being regarded as a powerhouse remote diagnostics.
Mr. Lucier received a bachelor’s degree in engineering from Pennsylvania State University and a masters of business administration from Harvard Business School. In addition to serving on the Board of NuVasive, he is a member of the Board of Directors for Catalent, Inc. and Invuity, Inc. Additionally, Mr. Lucier is a former Chairman of the Board of Life Technologies and director of CareFusion Corporation, now part of Becton, Dickinson & Co.
Lesley H. Howe
Lesley H. Howe has served as a member of our Board of Directors since February 2004. Mr. Howe has more than 40 years of experience in accounting, finance, and business management within a variety of industries. From December 2001 until May 2007, he served as Chief Executive Officer of Consumer Networks LLC, a San Diego-based Internet marketing and promotions company. During Mr. Howe’s 30-year career with KPMG Peat Marwick LLP, an international accounting and auditing firm, he was an audit partner for 23 years and an area managing partner/managing partner of the Los Angeles office of KPMG for three years. While there Mr. Howe worked as an independent financial and business consultant for three years, advising clients on acquisition due diligence and negotiation strategies, as well as financing strategies. Mr. Howe currently serves on the Board of Directors of Jamba Inc., the leading retailer of quality blended fruit beverages. Mr. Howe received a B.S. in Business Administration from the University of Arkansas.
Peter C. Farrell, Ph.D., AM
Peter C. Farrell, Ph.D., AM has served as a member of our Board of Directors since January 2005. Dr. Farrell was founding Chairman and Chief Executive Officer of ResMed, Inc., a leading developer and manufacturer of medical equipment for the diagnosis and treatment of sleep-disordered breathing. He held those positions from 1989 until 2007. Dr. Farrell holds bachelor’s and master’s degrees in Chemical Engineering from the University of Sydney and the Massachusetts Institute of Technology, a Ph.D. in Bioengineering from the University of Washington, Seattle, and a Doctor of Science from the University of New South Wales for research related to dialysis and renal medicine.
Vickie L. Capps
Vickie L. Capps has served as a member of our Board of Directors since June 2015. From July 2002 to December 2013, Ms. Capps served as the Chief Financial Officer of DJO Global, Inc. Prior to joining DJO Global, she served as the Chief Financial Officer of several other public and private companies. Earlier in her career, she served as a senior audit and accounting professional at Ernst & Young LLP. Ms. Capps is a member of the Senior Advisory Board of Consonance Capital Partners, a healthcare investment firm, and serves on the board of its portfolio company, Enclara Pharmacia. She also serves on the board of directors and as chair of the audit committees of RF Surgical Systems, Inc., Otonomy, Inc. and Connecture, Inc. Ms. Capps is a California Certified Public Accountant and was recognized as CFO of the Year by the San Diego Business Journal in 2009 and 2010. She earned a bachelor’s degree in business administration/accounting from San Diego State University.
Daniel J. Wolterman
Daniel J. Wolterman has served as a member of our Board of Directors since July 2015. Mr. Wolterman served as President and CEO of Memorial Hermann Health System from 2002 until his retirement in 2016. He has more than 30 years of experience in the healthcare industry and a long history of community involvement. He serves on the Joint Commission’s Center for Transforming Healthcare Leadership Advisory Council, and he continues to serve on the Greater Houston Partnership and Voluntary Hospitals of America boards of directors. He previously served on the board of directors of Volcano Corporation until the completion of its acquisition by Royal Philips in February of this year. Mr. Wolterman is also an Adjunct Professor at The University of Texas School of Public Health. Mr. Wolterman earned a B.S. degree in Business Administration in 1979 and a M.B.A. in Finance in 1980 from the University of Cincinnati and a Master’s Degree in Healthcare Administration from Xavier University in 1982.
Leslie V. Norwalk, Esq.
Leslie V. Norwalk, Esq. has served as a member of our Board of Directors since May 2014. Ms. Norwalk serves as a Strategic Advisor and Strategic Counsel to Epstein Becker & Green, P.C., EBG Advisors, Inc., and National Health Advisors. Ms. Norwalk is an Operating Partner at Enhanced Equity Fund, L.P. She serves as an Advisor to Warburg Pincus LLC, and Ferrer Freeman & Company. Previously, Ms. Norwalk served the Bush Administration as the Acting Administrator for the Centers for Medicare & Medicaid Services, where she managed the day-to-day operations of Medicare, Medicaid, State Child Health Insurance Programs, Survey and Certification of health care facilities and other federal health care initiatives. For four years prior to that, she was the agency’s Deputy Administrator, responsible for the implementation of the changes made under the Medicare Modernization Act, including the Medicare Prescription Drug Benefit. Prior to serving the Bush Administration, Ms. Norwalk practiced law in the Washington, D.C. office of Epstein Becker & Green, P.C. where she advised clients on a variety of health policy matters. She also served in the first Bush administration in the White House Office of Presidential Personnel, and the Office of the U.S. Trade Representative. In addition to NuVasive, Ms. Norwalk serves as a Director of the following organizations: Primary Care Associates Medical Group, Inc., ikaSystems Corporation, Press Ganey Associates, and Abode Healthcare. Ms. Norwalk also serves as Member of International Advisory Council at APCO Worldwide Inc. She earned a J.D. degree from the George Mason University School of Law and a bachelor’s degree, cum laude, in Economics and International Relations from Wellesley College.
Robert F. Friel
Robert F. Friel has served as a member of our Board of Directors since February 2016. With more than 35 years of finance and operational experience, Mr. Friel currently serves as Chairman, Chief Executive Officer and President of PerkinElmer, Inc., and has been one of the primary architects of the company’s transformation into a global technology leader focused on improving the health and safety of people and the environment. He previously served as President and Chief Operating Officer of PerkinElmer and as Vice Chairman and President of PerkinElmer’s Life and Analytical Sciences unit. Prior to that, Mr. Friel served as Executive Vice President and Chief Financial Officer of PerkinElmer with responsibility for business development and information technology in addition to his oversight of finance functions. Previously, he held several senior management positions with AlliedSignal, Inc., now Honeywell International. Mr. Friel received a Bachelor of Arts degree in economics from Lafayette College and a Master of Science degree in taxation from Fairleigh Dickinson University.
Donald J. Rosenberg
Donald J. Rosenberg has served as a member of our Board of Directors since February 2016. Mr. Rosenberg possesses extensive expertise in the areas of corporate governance, compliance, law department management, litigation, securities regulation, intellectual property and competition issues, which he developed over a 40-year career at leading Fortune 500 technology companies. He currently serves as Executive Vice President, General Counsel and Corporate Secretary of Qualcomm Incorporated, a world leader in 3G, 4G and next-generation wireless technologies. In this role, Mr. Rosenberg is responsible for overseeing Qualcomm’s worldwide legal affairs including litigation, intellectual property and corporate matters. Qualcomm’s Government Affairs, Corporate Compliance and Internal Audit departments also report to him. Prior to joining Qualcomm, he served as Senior Vice President, General Counsel and Corporate Secretary of Apple Inc. Prior to that, he was Senior Vice President and General Counsel of IBM Corporation. Mr. Rosenberg has served as an adjunct professor of law at New York’s Pace University School of Law, where he taught courses in intellectual property and antitrust law. He is the immediate past National Co-Chairman of the Board of the Lawyers’ Committee for Civil Rights Under Law. He received a Bachelor of Science degree in mathematics from the State University of New York at Stony Brook and his Juris Doctor from St. John’s University School of Law.
Patrick S. Miles
Patrick Miles has served as our Vice Chairman since September 2016 and has served as a member of NuVasive’s Board of Directors since August 2016. Mr. Miles is responsible for enhancing the Company’s strategic plans for the future of spine surgery and supporting technology development. Prior to that, he served as the Company’s President and Chief Operating Officer from February 2015 to September 2016; President of Global Products and Services from October 2011 to January 2015; President of the Americas from January 2010 to September 2011; Executive Vice President of Product Marketing and Development from January 2007 to December 2009; Senior Vice President of Marketing from December 2004 to January 2007; and Vice President, Marketing from January 2001 to December 2004. Mr. Miles has more than 25 years of experience in the orthopedic industry, including prior roles with Medtronic Sofamor Danek and Smith & Nephew. Mr. Miles received a B.S. in Finance from Mercer University.
Michael D. O’Halleran
Michael D. O’Halleran has served as a member of our Board of Directors since August 2016. With more than 40 years of business experience, Mr. O’Halleran currently serves as the executive chairman of Aon Benfield and senior vice president of Aon, plc, a provider of risk management, insurance and consulting service. Mr. O’Halleran joined the Aon group of companies in 1987 to lead its reinsurance division and since that time, has served in several significant management positions including president and chief operating officer of Aon Corporation, and since August 2007, as the executive chairman of Aon Benfield. Prior to joining Aon, he was a senior executive with well-known companies in the insurance industry. Mr. O’Halleran brings extensive healthcare and medical device governance experience, having served on the Board of Directors of Cardinal Health, Inc. from 1999-2009 and the Board of Directors of CareFusion Corporation from 2009-2015 (now part of Becton, Dickinson and Company). Mr. O’Halleran has a degree in Accounting and Finance from the University of Wisconsin-Whitewater.